CapsoVision (CV) EPS (Weighted Average and Diluted) (2024 - 2025)
CapsoVision's (CV) quarterly EPS (Weighted Average and Diluted) came in at $0.02 in Q4 2025, up 100.91% year-on-year from $0.01 in Q4 2024, and up 111.76% quarter-over-quarter from -$0.17 in Q3 2025.
CapsoVision (CV) EPS (Weighted Average and Diluted) (2024 - 2025) Analysis & Trends
CapsoVision has disclosed EPS (Weighted Average and Diluted) across 2 years of filings, most recently posting $0.02 for Q4 2025.
- EPS (Weighted Average and Diluted) for Q4 2025 came in at $0.02, up 100.91% year-over-year; the trailing twelve-month figure through Dec 2025 was -$4.37 (changed N/A YoY), and the FY2025 annual result was -$1.03, up 89.54% from the prior year.
- EPS (Weighted Average and Diluted) came in at $0.02 for Q4 2025 at CapsoVision, up from -$0.17 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.02 in Q4 2025 to a low of -$2.79 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 2.24 |
| 10 | CapsoVision | 161.82 Mn | 151.71 Mn | 1.95 Mn | 0.02 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.02 |
| Sep 30, 2025 | -0.17 |
| Jun 30, 2025 | -2.02 |
| Dec 31, 2024 | -2.20 |
| Sep 30, 2024 | -2.79 |
| Jun 30, 2024 | -2.58 |